ERBB2 and pachyonychia congenita: Aberrant human epidermal growth factor receptor-2 (HER2) signaling is implicated in various solid tumors, including BC, GC, biliary tract cancer, CRC, OC, and PC, where HER2 overexpression or amplification promotes tumor growth, invasion, and is associated with poor prognosis (168).